XM does not provide services to residents of the United States of America.
A
A

Arkema

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Arkema, Fuller Smith & Turner, Siemens Energy

EUROPE RESEARCH ROUNDUP- Arkema, Fuller Smith & Turner, Siemens Energy May 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Arkema, Fuller Smith & Turner and Siemens Energy, on Thursday. HIGHLIGHTS * Arkema SA AKE.PA : HSBC raises target price to EUR 117 from EUR 107 * Bytes Technology Group Plc BYIT.L : Deutsche Bank initiates coverage with buy rating * Fuller Smith & Turner Plc FSTA.L : Deutsche Bank initiates coverage with buy
A
A
A
A
B
B
B
B
C
E
E
G
A
A
B
D
G

Arkema rises after Q1 core profit beat, confirmed guidance

BUZZ-Arkema rises after Q1 core profit beat, confirmed guidance ** Shares in Arkema AKE.PA rise 3.2% after the French speciality chemicals group reported better than expected Q1 core profit figures and confirmed short and mid-term guidance ** Arkema reported Q1 EBITDA at 350 million euros ($376.64 million), while analysts expected 341 million euros
A

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch May 7 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. ARKEMA AKE.PA The company confirmed its full-year guidance, saying the operating profit in the second quarter will likely be slightly higher compared to last year.
A
L
S
V
U

Arkema Confirms 2024 Guidance

BRIEF-Arkema Confirms 2024 Guidance May 7 (Reuters) - Arkema SA AKE.PA : Q1 SALES EUR 2.34 BILLION VERSUS CONSENSUS EUR 2.39 BILLION Q1 CURRENT NET INCOME EUR 138 MILLION VERSUS EUR 162 MILLION YEAR AGO Q1 EBITDA EUR 350 MILLION VERSUS CONSENSUS EUR 341 MILLION OUTLOOK: Q2 EBITDA EXPECTED SLIGHTLY HIGHER THAN LAST YEAR CONFIRMS 2024 GUIDANCE EBITDA
A

Dow Advances Strategic Focus With Sale Of Flexible Packaging Laminating Adhesives Business To Arkema

BRIEF-Dow Advances Strategic Focus With Sale Of Flexible Packaging Laminating Adhesives Business To Arkema May 2 (Reuters) - Dow Inc DOW.N : DOW ADVANCES STRATEGIC FOCUS WITH SALE OF FLEXIBLE PACKAGING LAMINATING ADHESIVES BUSINESS TO ARKEMA DOW INC - TRANSACTION VALUE IS $150 MILLION OR APPROXIMATELY 10 TIMES FORECASTED 2024 EBITDA DOW INC - TRANS
A
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.